Tag: drug discovery
Opentrons raises $40M to hand lab benches over to robots
The Brooklyn lab-robot maker lands a $40M Series E led by Avego to push AI-designed experiments all the way through…
David Baker’s lab with Nvidia releases model that reasons about molecules
RFD4-Proteina pairs the Institute for Protein Design's RosettaFold Diffusion line with Nvidia's BioNeMo platform, lifting design success rates fivefold to…
Nearly 2,000 AI agents swept a brain atlas in 32 minutes
OpenAI, PerturbAI and Scripps Research split a whole-brain CRISPR dataset across nearly 2,000 GPT-Rosalind agents, finishing in 32 minutes what…
Toronto team builds an open data engine for peptide drugs
Toronto scientists build an open peptide data engine with $2.3M from Google.org
Astellas pays over $400M up front for proteins built from scratch
Astellas is handing AI Proteins a large upfront check to design miniprotein drugs that no natural molecule inspired.
OpenAI brings drug program tracking into its life sciences stack
OpenAI has absorbed Orchestra Bio to bolt drug program coordination onto Rosalind, its life sciences model family.
India puts 86 crore behind four AI designed drug candidates
India's Technology Development Board approved 86 crore rupees of support for Peptris, which will push four AI-discovered molecules into preclinical…
OMass raises $310M to take on Vertex in adrenal disease
Oxford-based OMass Therapeutics has raised $310 million in Series C financing, the second-largest private biotech round in Europe this year.